Login / Signup

RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness.

Yafeng LiuTao HanRui MiaoJiawei ZhouJianqiang GuoZhi XuYingru XingYing BaiJing WuDong Hu
Published in: BMC cancer (2024)
RACGAP1 not only indicates poor prognosis and limited immunotherapy benefits but also serves as a potential targeted biomarker influencing tumor stemness.
Keyphrases
  • poor prognosis
  • cell cycle
  • long non coding rna
  • stem cells
  • epithelial mesenchymal transition
  • cell proliferation
  • cancer stem cells
  • human health